Baxter Gross Profit 2010-2025 | BAX
Baxter annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Baxter gross profit for the quarter ending March 31, 2025 was $861M, a 10.41% decline year-over-year.
- Baxter gross profit for the twelve months ending March 31, 2025 was $3.884B, a 1.25% increase year-over-year.
- Baxter annual gross profit for 2024 was $3.984B, a 4% decline from 2023.
- Baxter annual gross profit for 2023 was $4.15B, a 16.93% increase from 2022.
- Baxter annual gross profit for 2022 was $3.549B, a 24.81% decline from 2021.
| Baxter Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $3,984 |
| 2023 | $4,150 |
| 2022 | $3,549 |
| 2021 | $4,720 |
| 2020 | $4,587 |
| 2019 | $4,761 |
| 2018 | $4,759 |
| 2017 | $4,474 |
| 2016 | $4,116 |
| 2015 | $4,146 |
| 2014 | $4,581 |
| 2013 | $4,162 |
| 2012 | $7,134 |
| 2011 | $7,046 |
| 2010 | $5,958 |
| 2009 | $6,525 |
| Baxter Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $861 |
| 2024-12-31 | $559 |
| 2024-09-30 | $1,033 |
| 2024-06-30 | $1,431 |
| 2024-03-31 | $961 |
| 2023-12-31 | $708 |
| 2023-09-30 | $1,056 |
| 2023-06-30 | $1,111 |
| 2023-03-31 | $1,275 |
| 2022-12-31 | $-215 |
| 2022-09-30 | $1,045 |
| 2022-06-30 | $1,371 |
| 2022-03-31 | $1,348 |
| 2021-12-31 | $1,021 |
| 2021-09-30 | $1,321 |
| 2021-06-30 | $1,233 |
| 2021-03-31 | $1,145 |
| 2020-12-31 | $1,191 |
| 2020-09-30 | $1,195 |
| 2020-06-30 | $1,038 |
| 2020-03-31 | $1,163 |
| 2019-12-31 | $1,298 |
| 2019-09-30 | $1,230 |
| 2019-06-30 | $1,153 |
| 2019-03-31 | $1,080 |
| 2018-12-31 | $1,174 |
| 2018-09-30 | $1,232 |
| 2018-06-30 | $1,239 |
| 2018-03-31 | $1,114 |
| 2017-12-31 | $1,168 |
| 2017-09-30 | $1,130 |
| 2017-06-30 | $1,132 |
| 2017-03-31 | $1,044 |
| 2016-12-31 | $1,108 |
| 2016-09-30 | $1,071 |
| 2016-06-30 | $972 |
| 2016-03-31 | $965 |
| 2015-12-31 | $1,072 |
| 2015-09-30 | $1,034 |
| 2015-06-30 | $1,021 |
| 2015-03-31 | $1,019 |
| 2014-12-31 | $1,207 |
| 2014-09-30 | $1,193 |
| 2014-06-30 | $1,969 |
| 2014-03-31 | $1,891 |
| 2013-12-31 | $1,996 |
| 2013-09-30 | $1,906 |
| 2013-06-30 | $1,939 |
| 2013-03-31 | $1,756 |
| 2012-12-31 | $1,738 |
| 2012-09-30 | $1,810 |
| 2012-06-30 | $1,872 |
| 2012-03-31 | $1,714 |
| 2011-12-31 | $1,765 |
| 2011-09-30 | $1,771 |
| 2011-06-30 | $1,835 |
| 2011-03-31 | $1,675 |
| 2010-12-31 | $1,618 |
| 2010-09-30 | $1,659 |
| 2010-06-30 | $1,638 |
| 2010-03-31 | $1,043 |
| 2009-12-31 | $1,767 |
| 2009-09-30 | $1,632 |
| 2009-06-30 | $1,638 |
| 2009-03-31 | $1,488 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.857B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.816B | 27.87 |
| Boston Scientific (BSX) | United States | $152.176B | 38.10 |
| Stryker (SYK) | United States | $145.393B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $127.544B | 0.00 |
| Medtronic (MDT) | Ireland | $107.067B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.941B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.439B | 27.54 |
| ResMed (RMD) | United States | $35.929B | 26.99 |
| GE HealthCare Technologies (GEHC) | United States | $31.992B | 15.19 |
| Agilent Technologies (A) | United States | $30.486B | 20.14 |
| Terumo (TRUMY) | Japan | $28.205B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.066B | 16.58 |
| Insulet (PODD) | United States | $21.859B | 85.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.837B | 12.10 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.412B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.686B | 22.60 |
| Lantheus Holdings (LNTH) | United States | $5.598B | 14.27 |
| Prestige Consumer Healthcare (PBH) | United States | $4.325B | 19.27 |
| Perrigo (PRGO) | Ireland | $3.713B | 9.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.426B | 14.92 |
| ICU Medical (ICUI) | United States | $3.404B | 25.10 |
| Envista Holdings (NVST) | United States | $2.981B | 24.77 |
| QuidelOrtho (QDEL) | United States | $2.451B | 16.90 |
| GN Store Nord (GNNDY) | Denmark | $2.075B | 17.19 |
| LeMaitre Vascular (LMAT) | United States | $1.813B | 40.54 |
| AtriCure (ATRC) | United States | $1.534B | 0.00 |
| Neogen (NEOG) | United States | $1.296B | 16.58 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.164B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.156B | 11.75 |
| BioLife Solutions (BLFS) | United States | $1.106B | 0.00 |
| InMode (INMD) | Israel | $1.005B | 9.20 |
| Phibro Animal Health (PAHC) | United States | $0.910B | 11.64 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.575B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Owens & Minor (OMI) | United States | $0.542B | 4.49 |
| Valneva SE (VALN) | France | $0.541B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Omeros (OMER) | United States | $0.360B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.290B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.283B | 10.42 |
| Aurora Cannabis (ACB) | Canada | $0.273B | 48.50 |
| Sanuwave Health (SNWV) | United States | $0.257B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.250B | 21.07 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.09 |
| Canopy Growth (CGC) | Canada | $0.241B | 0.00 |
| Biote (BTMD) | United States | $0.219B | 6.15 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.18 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.162B | 0.00 |
| Organigram Global (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.16 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.103B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.77 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| United-Guardian (UG) | United States | $0.037B | 12.79 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |